Regenerative Medical Technology Group Inc. (RMTG)
About Regenerative Medical Technology Group Inc.
REGENERATIVE MEDICAL TECH
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $5.1M
- Net income
- -$7.8M
- Total assets
- $4.5M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Regenerative Medical Technology Group Inc. (RMTG) Stock Price
- Reported a net loss of $7.8M in FY2025.
- Trading 25% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Regenerative Medical Technology Group Inc..
Write a review
Regenerative Medical Technology Group Inc.: frequently asked questions
Is Regenerative Medical Technology Group Inc. an American company?
Regenerative Medical Technology Group Inc. is a US-based company headquartered in Boca Raton, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Regenerative Medical Technology Group Inc. headquartered?
Regenerative Medical Technology Group Inc. is headquartered in Boca Raton, Florida, United States.
Is Regenerative Medical Technology Group Inc. publicly traded?
Yes — Regenerative Medical Technology Group Inc. is a publicly traded company. Its stock trades under the ticker symbol RMTG on the OTC.
